Best Life Sciences Companies in Turkey
The 128 best Life Sciences companies in Turkey in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: RS Research.
Turkey's Life Sciences sector has 128 companies on our radar, and the total disclosed equity funding sits at $21M — modest in absolute terms, but the distribution tells you where the real bets are. Rs Research leads the pack at $13M, followed by Tarabios at $4M and KuartisMED at $2M. So roughly 90% of tracked funding is concentrated in three names. That's not unusual for an emerging market cluster, and it does mean the rest of the field is mostly pre-institutional. Backers like Europa, EIC Fund, and Cube Incubation are the ones moving early, which tracks with a broader global pattern: life sciences capital keeps concentrating around a handful of high-conviction platforms rather than spreading thin.
The global market context matters here. Life sciences worldwide was valued around $167.8B (2004 baseline) and has been compounding at roughly 10.2% CAGR since, driven by aging demographics and accelerating institutional funding. Turkey doesn't have a unicorn yet in this space, but I'd watch the digital health layer closely — median app install growth across healthcare and life sciences apps is running at +43% YoY across 15 tracked platforms, which signals real end-user pull. And SAI Life Sciences' IPO move shows how fast a regional player can scale once institutional momentum kicks in. Could Turkey's next funding round break that $21M ceiling? The pipeline suggests it's a matter of when.
- What Drives San Diego's Life Sciences Industry
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Turkey
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | RS Research Developer of targeted therapies using polymer-drug conjugates for drug delivery | $13M | 29 mo ago | Series A | — | 2015 | WordPressMySQLPHP+16 | — |
| 2 | Tarabios Developer of self diagnostic device for blood coagulation time | $4M | 63 mo ago | Seed | Hasan Urey CEO | 2019 | — | — |
| 3 | KuartisMED Developer of a device to assess feeding maturity of preterm babies | $2M | 42 mo ago | Seed | Aylin Tarcan Co-Founder | 2012 | — | — |
| 4 | Inofab Health Provider of spirometer app for respiratory management | $1M | 65 mo ago | Acquired | Merthan Ozturk Co-Founder & CEO | 2014 | — | — |
| 5 | BioCapSol Focuses on extraction of biological content from plants | $648K | 82 mo ago | Deadpooled | — | 2016 | — | — |
| 6 | GlakoLens Developer of non-invasive diagnostic to monitor intraocular pressure in glaucoma | $520K | 71 mo ago | Seed | Gunhan Dundar Co-Founder & Board Member | 2017 | — | — |
| 7 | MITOS Medical Technologies Developer of microwave breast tomography for image diagnosis | $282K | 97 mo ago | Funding Raised | — | 2010 | — | — |
| 8 | ZipPrime Provider of a solution to capture, detect and preserve the rare and fragile circulating free DNA molecules | $111K | 123 mo ago | Funding Raised | Sila Ataca Co-Founder | 2008 | — | — |
| 9 | Matriks Biotek Developer of ELISA kits to monitor biological drugs | $111K | 76 mo ago | Funding Raised | Haluk Ataoglu Founder & CEO | 2002 | — | 1 launch |
Top 12 Life Sciences companies in Turkey
#1
Series A · Pendik, Istanbul · founded 2015 · 19 employees$13.2Mraised▾
Developer of targeted therapies using polymer-drug conjugates for drug delivery. The company focuses on improving therapeutic index across payloads with active targeting and optimized pharmacokinetics. It addresses the efficacy-toxicity trade-off in oncology. The company's technology uses clinically validated polymer-drug conjugates. It designs tumor-targeted prodrugs to enhance the therapeutic index of docetaxel.
- Jan 2024Grant (prize money)$40.7K
- Dec 2021Series A$12M
- Apr 2017Seed$1.2M
- Jan 2016Grant (prize money)$171K
#2
Seed · Ankara, Ankara · founded 2012 · 25 employees$1.8Mraised▾
Developer of a device to assess the feeding maturity of preterm babies. The company's devices include Neosafe which is a non-invasive biomedical diagnostic device for monitoring the feeding ability of newborns.
- Nov 2022Seed$1.8M
- Feb 2019Grant (prize money)$1.7M
- Mar 2017Grant (prize money)$1.5M
- Jan 2017Grant (prize money)$1.5M
#3
Seed · Sarıyer, Istanbul · founded 2019$3.5Mraised▾
Developer of coagulation monitoring systems intended to improve the efficiency of healthcare professionals and patients' quality of life. The company provides a PoC coagulometer, a hand-held device that performs individual tests on fresh (or citrated) whole blood, helping patients with a self-care home monitoring device at their ease.
#4
Acquired · Ankara, Ankara · founded 2014 · 37 employees$1Mraised▾
InfoLab provides a spirometer app for respiratory management. The app helps in managing and monitoring respiratory health. Spire Home personal is a spirometer designed for asthma, COPD, and cystic fibrosis patients to help quantify their lung health. It enables patients to monitor their disease. For clinics, the Spirohome clinic ultrasonic spirometer delivers high-quality spirometry results using ultrasonic flow seeing to diagnose patients and collate the results on the dashboard.
- Jan 2021Seed$1M
#5
Seed · Istanbul, Istanbul · founded 2017 · 13 employees$520.2Kraised▾
Developer of contact lens-based biosensor technology designed for intraocular pressure and glaucoma management. The company's technology offers non-invasive continuous intraocular pressure diagnostics and monitoring devices to accurately diagnose and passively monitor fluctuations in IOP by measuring certain properties of the eye, enabling doctors to effectively treat glaucoma using various monitoring devices that offer insights.
#6
Deadpooled · Istanbul, Istanbul · founded 2016 · 5 employees$648.2Kraised▾
BioCapSol engages in extracting biological content from plants and vegetables to provide active ingredient as a function of time, temperature, chemical and physical conditions based on encapsulation technology. Its product portfolio ranges from biological extracts (food coloring and Lycopene) to functional additives (functionalized capsules).
- Aug 2019Grant (prize money)$55.4K
- Aug 2016Seed$592.8K
#7
Seed · Serdivan, Sakarya Province · founded 2016 · 1 employees$50Kraised▾
Developer of wearable medical devices for stroke rehabilitation. The company's product ExoRehab X is an exoskeletal device for upper extremity resistance therapy. It improves muscular strength and endurance, provides visual feedback, and objective assessment of patient's movement.
- Mar 2022Seed—
- Jan 2021Seed$50K
#8
Funding Raised · Ankara, Ankara · founded 2002$110.5Kraised▾
Developer of ELISA kits to monitor biological drugs. The company offers a range of products, including SHIKARI ELISA kits and Coronahunter ELISA kits for COVID-19, which are enzyme immunoassays for the qualitative and quantitative determination of specific antibodies to various drugs and biologics.
- Jan 2020Grant (prize money)$55.1K
- Aug 2019Grant (prize money)$55.4K
#9
Funding Raised · Istanbul, Istanbul · founded 2010 · 10 employees$282.5Kraised▾
Mitos Medikal develops a patented microwave breast tomography device for image diagnosis. It uses radio waves and strong magnetic fields to make images of the inside body. This method utilizes the amount of absorption energy of different types of tissues. When used with soft tissue like breast, contrast chemical liquid is injected to provide images.
- May 2018Grant (prize money)$282.5K
#10
Funding Raised · Esenler, Istanbul · founded 2016 · 3 employees$56Kraised▾
Provider of cloud-based sweat analyzing biosensors. It offers sweat-based glucose monitoring devices for people with diabetes. It monitors and sends blood correlated sweat glucose data to a cloud-integrated mobile application. It allows the patients to track their glucose level continuously. It also enables doctors to monitor their patients remotely.
- Nov 2019Grant (prize money)$56K
#11
Funding Raised · Ankara, Ankara · founded 2008$111.1Kraised▾
Provider of a solution to capture, detect and preserve the rare and fragile circulating free DNA molecules. The company offers molecular targeting, capturing, and storage technology is known as SME Instrument is used for the early detection of cancer.
- Feb 2016Grant (prize money)$54.6K
- Sep 2015Grant (prize money)$56.5K
#12
Funding Raised · Izmir, Aegean Region · founded 1998—raised▾
Provider of hospital and laboratory information management system for healthcare providers. The platform provides seamless integration of documentation and administration works of all the transactions and hospital data. The radiology imaging and archiving system integrate all medical imaging devices that support the DICOM standard and integrated them into the PACS system. The laboratory work and all the data blood collection kiosks and system data processed are analyzed. The reporting system along with the clinical decision support tools provide interpretation for the results obtained.
- Dec 2020Unattributed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Turkey
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 703 Turkey-affiliated papers.
- Ankara University38
- Atatürk University28
- Sağlık Bilimleri Üniversitesi26
- Selçuk University26
- Ministry of Health25
- Gene7
- Genetic diversity5
- Spinosad3
- Larvicide3
- Larva3
- Fermentation1→19
- Agriculture2→17
- Cytotoxicity1→15
- Viability assay1→13
- Biomass (ecology)1→8
- Antibiotic resistance8
- Antimicrobial8
- Food safety7
- Antibiotics6
- Sustainability6
Where biotechnology is researched across Turkey
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.